Quoin Pharmaceuticals, Ltd. (QNRX) Insider Trading

Name: Quoin Pharmaceuticals, Ltd. (QNRX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 1, 2026): Carter Denise P. (Chief Operating Officer): Purchase of 20,490 shares, $100.0K.

Get alerted when insiders trade QNRX

Email address

Loading company data...

Beta

Loading company details...

Beta